[Tumor serodiagnosis with monoclonal antibodies]

The applicability of monoclonal antibodies (MAb) to the serological diagnosis of solid tumours is discussed. So far test kits with MAb cannot claim higher resolution of specificity as compared with conventional antisera. One approach to solve this problem would be to produce MAb to peptides derived from tumour extracts which are unique to malignant tissue.